Review Article
Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders
Table 1
Studies demonstrating evidence or absence of C. pneumoniae in brain autoptic specimens from patients with Alzheimer disease.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCR, polymerase chain reaction; ≠RT-PCR, Reverse transcriptase PCR; IHM, immunoistochemistry; *EM, electron microscopy; §primers targeting the 16S ribosomal RNA (rRNA) gene (Gaydos et al., J Clin Microbiol 1992; 30: 796–800) and the chlamydial major outer membrane protein (MOMP) gene (ompA) (Perez-Melgosa et al., Infect Imm 1991; 59: 2195–9); †PCR with seminested primer amplifying C. pneumoniae-specific DNA sequences of 437 bp (Kuo et al, J Infect Dis 1993; 167: 841-9); °nested PCR (Maass et al., Atherosclerosis 1998; 140: S25–30); °°Primers targeting the MOMP gene (Perez-Melgosa et al., 1991; Infect Imm 1991; 59: 2195–9) •PCR using the 76 kDa protein gene [47], the rpoB gene encoding the RNA polymerase beta subunit (Ouchi et al., J Med Microbiol 1998; 47: 907–13), and the pan-Chlamydia primers targeting the 16S ribosomal RNA gene in Chlamydia and Chlamydia-like organisms (Ossewaarde et al., Microbiology 1999; 145: 411–17); °°°PCR with primer targeting the 16SrRNA gene (J Clin Microbiol 1992; 30: 796–800); ‡PCR-multiple assays targeting the Cpn1046 gene (aromatic amino acid hydroxylase) and Cpn0695 (MOMP)[54]. |